MarketersMEDIA / Newsroom / Duloxetine API Market Outlook to 2023 – Size, Market Players, Regional Overview, Segments, Key Trends, Types, SWOT Analysis | MRFR

Duloxetine API Market Outlook to 2023 – Size, Market Players, Regional Overview, Segments, Key Trends, Types, SWOT Analysis | MRFR

Share This Press Release

Market Research Future (MRFR) Has Announced a New Release on the Global Duloxetine API Market. The primary objective of the report is to analyses the current market landscape and its future potential.

— The prominent players in the global duloxetine API market are Teva Pharmaceutical Industries Ltd (Israel), Sun Pharmaceutical Industries Ltd (India), Aurobindo Pharma (India), Lupin (India), Zydus Cadila (India), Eli Lilly and Company (United States), Shodhana Laboratories (India), Hetero (India), Apotex Inc. (Canada), Shionogi Inc. (US), and Zhejiang Huahai Pharmaceutical Co., Ltd (China).

The Global Duloxetine API Market is expected to register a CAGR of 3.52% and is anticipated to reach USD 3,985.0 million by 2023. Active pharmaceutical ingredients (APIs) are used in the manufacturing of pharmaceutical dosage forms such as tablets and capsules. Duloxetine is a serotonin-norepinephrine reuptake inhibitor used in the treatment of depression and anxiety. Additionally, duloxetine API is used to help relieve neuropathic pain in people with diabetes or ongoing pain due to disease conditions such as arthritis, fibromyalgia, and chronic back pain.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/7707

The factors such as the rising prevalence of depression, growing penetration of generic drugs, growing cases of anxiety, the growing trend of outsourcing, strong drug pipeline, and increasing demand for newly developed small molecule drugs are expected to drive the market growth during the forecast period.

Segmentation:

The global duloxetine API market has been segmented into application. Based on application, the market has been segmented into major depressive disorder, generalized anxiety disorder, fibromyalgia, neuropathic pain, chronic musculoskeletal pain, and others. The chronic musculoskeletal pain accounted for a market value of USD 200.0 million in 2017.

Regional Analysis:

Geographically, the Americas is expected to dominate the global duloxetine API market. In this region, North America is expected to dominate the market owing to the increasing incidence of chronic diseases such as psychological disorders, diabetes, increasing government focus on generic drugs, and technological advancements in the manufacturing processes of APIs. In Europe, the market growth is majorly due to the increasing pharmaceutical sector. Additionally, in Europe, countries such as the UK, Germany, and France have a higher demand for API and thereby drive the growth of the overall market. The Asia-Pacific market for duloxetine API is considered to be growing significantly due to the rising healthcare spending and a growing number of contract manufacturing organizations (CMOs). In this region, Japan accounted for a market share of 13.7% in 2017. Moreover, the Middle East and Africa accounted for the least share of the market. The low market share is due to the limited number of companies manufacturing duloxetine API.

TOC:

1  Executive Summary$ 1,350.00

2  Market Introduction$ 0.00

3  Research Methodology$ 0.00

4  Market Dynamics$ 950.00

5  Market Factor Analysis$ 950.00

6  Global Duloxetine API Market by Application$ 2,400.00

7  Global Duloxetine API Market by Region$ 2,400.00

8  Competitive Landscape$ 1,050.00

9  Company Profiles$ 900.00

10  Appendix$ 0.00

List of Tables:

TABLE 1 DIFFERENCES IN THE API REGISTRATION REQUIREMENTS IN THE US AND EU 28

TABLE 2 SPECIFICATIONS FOR DULOXETINE 29

TABLE 3 PRICE RANGE FOR DULOXETINE API (USD/KG) 30

TABLE 4 PATENT ANALYSIS FOR THE GLOBAL DULOXETINE API MARKET 31

TABLE 5 DULOXETINE API MARKET: PRODUCT PIPELINE ANALYSIS 33

TABLE 6 GLOBAL DULOXETINE API MARKET, BY APPLICATION, 2015–2023 (USD MILLION) 36

TABLE 7 GLOBAL DULOXETINE API MARKET FOR MAJOR DEPRESSIVE DISORDER, BY REGION, 2015–2023 (USD MILLION) 37

TABLE 8 GLOBAL DULOXETINE API MARKET FOR GENERALIZED ANXIETY DISORDER (GAD), BY REGION, 2015–2023 (USD MILLION) 38

TABLE 9 GLOBAL DULOXETINE API MARKET FOR FIBROMYALGIA, BY REGION, 2015–2023 (USD MILLION) 39

TABLE 10 GLOBAL DULOXETINE API MARKET FOR NEUROPATHIC PAIN, BY REGION, 2015–2023 (USD MILLION) 40

Continued…

Browse more Information on This Report at https://www.marketresearchfuture.com/reports/duloxetine-api-market-7707

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Abhishek Sawant
Email: Send Email
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
Phone: 6468459312
Website: https://www.marketresearchfuture.com/reports/duloxetine-api-market-7707

Source URL: https://marketersmedia.com/duloxetine-api-market-outlook-to-2023-size-market-players-regional-overview-segments-key-trends-types-swot-analysis-mrfr/88917998

Source: MarketersMedia

Release ID: 88917998

Subscribe and Receive exclusive insider tips and tricks on Press Release.

Follow Us

Copyright © 2012 - 2019 MarketersMEDIA – Press Release Distribution Services – News Release Distribution Services. All Rights Reserved.

Powered by Semantics BigData Analytics (SBDA).